Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-5.43% | -9.50% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an expected P/E ratio at 32.17 and 28.51 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.92 times its current sales, is high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.50% | 66.25B | - | ||
-6.24% | 180B | C+ | ||
-6.08% | 99.21B | C | ||
-9.35% | 44.74B | B- | ||
+8.34% | 43.82B | B- | ||
+10.35% | 41.96B | B+ | ||
+11.88% | 28.98B | B | ||
-8.38% | 23.5B | A- | ||
+16.18% | 24.07B | A- | ||
-12.68% | 21.86B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BDX Stock
- BDXA Stock
- Ratings Becton, Dickinson and Company